Clinical Trial Update: Nitazoxanide Versus Placebo for the Treatment of Hospitalized Subjects With Severe Acute Respiratory Illness [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nitazoxanide versus placebo for hospitalized patients with severe acute respiratory illness completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Illness

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Severe Acute Respiratory Illness | Phase 2 | Status: COMPLETED | Results posted: 2018-07-31